+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antipsychotic Drug"

Tourettes Syndrome Drugs Market 2025-2029 - Product Thumbnail Image

Tourettes Syndrome Drugs Market 2025-2029

  • Report
  • June 2025
  • 197 Pages
  • Global
From
Treatment Resistant Depression Therapeutics Market 2025-2029 - Product Thumbnail Image

Treatment Resistant Depression Therapeutics Market 2025-2029

  • Report
  • December 2024
  • 201 Pages
  • Global
From
Schizophrenia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Schizophrenia Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
From
Treatment Resistant Depression Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Treatment Resistant Depression Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Trichotillomania (TTM) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Trichotillomania (TTM) Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
Fragile X Syndrome: Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Fragile X Syndrome: Opportunity Assessment and Forecast - Update

  • Report
  • February 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth. The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more